Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

4 analysts have shared their evaluations of Collegium Pharmaceutical COLL during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot ...

Investors eyeing a purchase of Collegium Pharmaceutical Inc (Symbol: COLL) stock, but cautious about paying the going market price of $35.97/share, might benefit from considering selling puts ...

Collegium Charter School contains 1 schools and 2,861 students. The district’s minority enrollment is 60%. Also, 45.8% of students are economically disadvantaged. The student body at the schools ...

STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of ...

The most recent trading session ended with Collegium Pharmaceutical (COLL) standing at $38.79, reflecting a -1.6% shift from the previouse trading day's closing. The stock's performance was behind ...

The Supreme Court Collegium has rejected the Centre's objection to the elevation of advocate Manoj Pulamby Madhavan as a judge of the Kerala High Court. In its resolution passed on March 12 ...

N EW DELHI: Despite being notified six months ago, the collegium system in AIIMS New Delhi is yet to be implemented properly. Sources said that over 80% of the departments at the institute have ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...